Fig. 3From: Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failureKaplan–Meier analyses for survival according to plasma SOD levels. A ROC curve for MELD score; B ROC curve for plasma SOD; C Plasma SOD (above or below 400 U/mL) identifies HEV-ALF patients with higher mortality; D Plasma SOD (above or below 400 U/mL) identifies HEV-ACLF patients with higher mortalityBack to article page